Glassman Wealth Services - SAGE THERAPEUTICS INC ownership

SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 228 filers reported holding SAGE THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 2.20 and the average weighting 0.1%.

Quarter-by-quarter ownership
Glassman Wealth Services ownership history of SAGE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$1,585
-87.8%
77
-74.4%
0.00%
-100.0%
Q4 2021$13,000
+550.0%
301
+514.3%
0.00%
Q3 2021$2,000
-71.4%
49
-61.4%
0.00%
-100.0%
Q2 2021$7,000
-22.2%
127
+1.6%
0.00%
-50.0%
Q1 2021$9,000
-59.1%
125
-50.0%
0.00%
-33.3%
Q4 2020$22,000
+633.3%
250
+455.6%
0.00%
+200.0%
Q3 2020$3,000
+50.0%
450.0%0.00%0.0%
Q2 2020$2,000
+100.0%
45
+95.7%
0.00%
Q1 2020$1,00023
+666.7%
0.00%
Q4 2019$0
-100.0%
3
-66.7%
0.00%
-100.0%
Q2 2019$2,00090.00%
Other shareholders
SAGE THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Integral Health Asset Management, LLC 311,000$10,294,0002.68%
Palo Alto Investors LP 851,719$28,192,0002.18%
Boxer Capital, LLC 1,094,000$36,211,0001.86%
DAFNA Capital Management LLC 180,306$5,968,0001.56%
Deep Track Capital, LP 675,000$22,343,0001.43%
Bellevue Group AG 3,052,404$101,034,0001.17%
Ikarian Capital, LLC 249,907$8,272,0001.09%
Ikarian Capital, LLC 250,000$8,275,0001.09%
Artal Group S.A. 750,000$24,825,0001.04%
SECTOR GAMMA AS 118,476$3,922,0000.85%
View complete list of SAGE THERAPEUTICS INC shareholders